COL5A1 overexpression correlates with poor prognosis in human cervical cancer
Authors:
Open Access
- 23 July 2024
- journal article
- research article
- Published by SAGE Publications in The International Journal of Biological Markers
- Vol. 39 (3) , 265-273
Abstract
Background: Cervical cancer is the most prevalent malignant tumor in women. This study aims to detect collagen type V α1 chain (COL5A1) expression and its clinical relevance in the prognosis of patients with cervical cancer. Methods: Cervical cancer tissues and their paired adjacent normal tissues were prepared for tissue microarray. The expression of COL5A1 protein and the scores of the expression were evaluated by immunohistochemistry (IHC) staining. The prognostic value of COL5A1 was analyzed by R software version 4.2.1 with “survival, survminer, ggplot2” packages and Gene Expression Profiling Interactive Analysis (GEPIA). The cBioPortal database was utilized for the analysis of COL5A1 gene mutations. Results: COL5A1 protein was overexpressed in human cervical cancer tissues compared to their paired adjacent normal tissues detected by IHC ( P < 0.001). High expression of COL5A1 tends to be in elderly patients with cervical cancer. Survival analyses of clinical data of patients with cervical cancer showed that a high level of COL5A1 expression was significantly correlated with shorter overall survival ( P = 0.031) and disease-free survival ( P = 0.042) of patients. Further analyses of The Cancer Genome Atlas-Cervical Squamous Cell Carcinoma and the GEPIA survival datasets confirmed the association of high COL5A1 expression with poor overall survival of patients ( P = 0.040 and P = 0.018, respectively). The analysis of genomic alterations of COL5A1 using the cBioPortal tool revealed that the COL5A1 gene was altered in 4% of cervical cancer patients and COL5A1 corresponding protein alterations with post-translational modifications were hydroxylation. Conclusion: COL5A1 is a tissue biomarker correlated with the poor prognosis of patients with cervical cancer, which may lead to a new clinical application.Keywords
Funding Information
- Natural Science Foundation of Shanghai Municipality (23ZR1408900)
- Start-up fund of research from Jinshan Hospital (JYQN-LC-202101)
- Project of the Science and Technology Commission of Shanghai Municipality (20Y11914100)
This publication has 35 references indexed in Scilit:
- Cancer biomarkers: Emerging trends and clinical implications for personalized treatmentCell, 2024
- Self-sampling for HPV testing in cervical cancer screening: A scoping reviewEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2024
- CircBFAR correlates with poor prognosis and promotes laryngeal squamous cell cancer progression through miR‐31‐5p/COL5A1 axisLaryngoscope Investigative Otolaryngology, 2022
- Type V collagen alpha 1 chain promotes the malignancy of glioblastoma through PPRC1-ESM1 axis activation and extracellular matrix remodelingCell Death Discovery, 2021
- Overexpressed COL5A1 is correlated with tumor progression, paclitaxel resistance, and tumor‐infiltrating immune cells in ovarian cancerJournal of Cellular Physiology, 2021
- Head and neck squamous cell carcinomaNature Reviews Disease Primers, 2020
- Concepts of extracellular matrix remodelling in tumour progression and metastasisNature Communications, 2020
- LncRNA HOTAIR promotes the growth and metastasis of gastric cancer by sponging miR-1277-5p and upregulating COL5A1Gastric Cancer, 2020
- CircACAP2 promotes breast cancer proliferation and metastasis by targeting miR-29a/b-3p-COL5A1 axisLife Sciences, 2020
- COL5A1 may contribute the metastasis of lung adenocarcinomaGene, 2018